ONO-2745 Open-label Study

ONO-2745 Open-label Study Multi-center, double-blind, randomized, parallel-group study in patients undergoing surgery requiring general anesthesia.

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221932

Enrollment

Registered

2012-10-02

Start date

2012-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing surgery requiring general anesthesia.

Interventions

investigational material(s) Generic name etc : ONO-2745 INN of investigational material : remimazolam Therapeutic category code : 111 General anesthetics Dosage and Administration for Investigational

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients planned to undergo artificial ventilation management by tracheal intubation 2. ASA (American Society of Anesthesiologists) classification III or higher

Exclusion criteria

Exclusion criteria: 1. Patients undergoing emergency operation

Design outcomes

Primary

Measure	Time frame
Efficacy (with or without intraoperative awakening, memory, rescue therapy for sedative effect, body motion)	—

Secondary

Measure	Time frame
Efficacy, safety, pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026